Department of Surgery, Amphia Hospital, Breda, The Netherlands.
PLoS One. 2013;8(2):e55964. doi: 10.1371/journal.pone.0055964. Epub 2013 Feb 7.
C-reactive Protein (CRP) is used next to clinical scoring systems to recognize critically ill patients prone to develop complications on the Intensive Care Unit (ICU). The purpose of this study is to assess the predictive value of CRP as parameter for clinical deterioration and/or clinical decision making as ordering diagnostic procedures or performing (re)interventions. Also, we wanted to determine the value of CRP in early detection of surgical complications in the critically ill general surgical patient in the ICU and its interpretation in adjunct to a clinical scoring system, the Sequential Organ Failure Assessment Score.
In our prospective observational study, 174 general surgical patients admitted into the Intensive Care Unit were included. We evaluated the Sequential Organ Failure Assessment Score (SOFA) and daily measured the C-reactive protein (CRP) concentrations. All events (diagnostic or therapeutic interventions) and surgical complications were registered. Then the relationship between SOFA score, CRP concentrations, events and complications were studied.
Each 10% increase in CRP resulted in a 3.5% increase in the odds of an event (odds ratio 1.035, 95% CI: 1.004-1.068; p = 0.028). However, an increase in CRP levels did not lead to a higher odds of complication (OR 0.983, 95% CI: 0.932-1.036; p = 0.52). When adjusting for the SOFA score the effect of CRP on the probability of a first event remained significant (OR 1.033, 95% CI: 1.001-1.065; p = 0.046), and again did not significantly affect the complication probability (OR 0.980, 95% CI: 0.929-1.035; p = 0.46).
An increase in C-reactive protein is a poor parameter for early detection of complications in the critically ill surgical patient in the ICU by means of diagnostic procedures or therapeutic (re)-interventions.
C 反应蛋白(CRP)除了临床评分系统外,还用于识别有发生 ICU 并发症风险的危重症患者。本研究旨在评估 CRP 作为预测临床恶化和/或临床决策的参数的价值,例如决定进行诊断程序或实施(再次)干预。此外,我们还希望确定 CRP 在 ICU 中重症普通外科患者早期检测手术并发症的价值,并结合临床评分系统(序贯器官衰竭评估评分)对其进行解释。
在我们的前瞻性观察性研究中,纳入了 174 名入住 ICU 的普通外科患者。我们评估了序贯器官衰竭评估评分(SOFA),并每天测量 C 反应蛋白(CRP)浓度。所有事件(诊断或治疗干预)和手术并发症均被记录。然后研究 SOFA 评分、CRP 浓度、事件和并发症之间的关系。
CRP 每增加 10%,事件发生的几率增加 3.5%(比值比 1.035,95%置信区间:1.004-1.068;p=0.028)。然而,CRP 水平的升高并没有导致并发症发生几率的增加(OR 0.983,95%置信区间:0.932-1.036;p=0.52)。在校正 SOFA 评分后,CRP 对首次事件概率的影响仍然显著(OR 1.033,95%置信区间:1.001-1.065;p=0.046),并且再次对并发症发生几率没有显著影响(OR 0.980,95%置信区间:0.929-1.035;p=0.46)。
CRP 升高不能作为 ICU 中重症外科患者通过诊断程序或治疗(再次)干预早期检测并发症的有效参数。